View Article

Abstract

Peptic ulcer is a long-term disease, that mainly occur due to imbalance between aggressive factor like acid secretion and protective mechanism of stomach lining. One of the key enzymes in acid secretion is H?/K?-ATPase. Current antiulcer drug is associated with side effects and recurrence. Therefore, there is a need to develop safer alternatives from natural sources. In the present study phytochemicals from bauhinia acuminata were assessed for their potential antiulcer property using molecular docking and ADMET analysis. Nine compounds were chosen based on literature and subjected to in-silico studies against H?/K?-ATPase using three protein structures. Among the tested compounds, Phlorizin, Quercetin, and Baicalein showed strong binding affinities, with Phlorizin exhibiting the highest docking score. These compounds exhibited interactions effectively through important key amino acid residues in the active site, indicating good inhibitory potential. Further ADMET analysis revealed that most compounds possessed acceptable pharmacokinetic properties and followed Lipinski’s rule of five. Notably, Quercetin demonstrated a good balance between binding efficiency and drug-likeness, making it a promising candidate. Overall, the findings suggest that phytochemicals from Bauhinia acuminata, especially Quercetin, may serve as potential natural inhibitors of H?/K?-ATPase. However, further experimental studies are required to confirm their antiulcer activity and therapeutic applicability.

Keywords

Bauhinia acuminata, H?/K?-ATPase, Molecular docking, ADMET analysis, Peptic ulcer

Introduction

× Popup Image

Peptic ulcers are a chronic and recurrent illness caused by damage to the duodenal or stomach mucosa due to an imbalance between the mucosal defensive factors and the gastric aggressive factor 1. Exogenous aggressive factors include stress, alcohol, smoking, use of anti-inflammatory drugs, consuming fatty foods, and infection caused by Helicobacter pylori. HCl together with pepsin, pancreatic enzymes, and bile, weakens the protective barrier of the gastrointestinal mucosa 2. Symptoms often appear several hours after eating, when the food has exited the stomach, but acid production is high, and include bleeding and other symptoms. Pain in the upper abdomen is a common symptom of ulcers. Therefore, the importance of active phytoconstituents in the treatment of peptic ulcers has been explored.

Ulcers cause pain in the upper abdomen, and bleeding and other symptoms are often not felt until several hours after a meal, once the food has left the stomach, but the acid production remains high. Therefore, there has been an attempt to examine the role of active phytoconstituents in the treatment of peptic ulcers 3. Gastric proton pump is the main enzyme in charge of making stomach contents more acidic. The proton pump is located in the very specialized stomach epithelial cell known as parietal cells 4. Gastric proton pump is a key part of making acid because it moves H+ into the lumen in exchange for K+ 5. The most commonly used acid-suppressive drugs in the world are proton pump inhibitors, including omeprazole, esomeprazole, pantoprazole, lansoprazole, rabeprazole, and dexlansoprazole 6. However, these compounds function in an acidic canalicular pH in parietal cells, and their half-life in plasma is very short 4.

Recently, the use of natural products and alternative therapies has become more popular 1. While there are numerous synthetic antiulcer medications, the severe long-term side effects have led to more research into plant-based alternatives 7. Dwarf white bauhinia (Bauhinia acuminata) belongs to the Fabaceae family and contains phytochemicals including palmitic acid, phallic acid, esterified acid, gallic acid ursolic acid, carbohydrate, alkaloids, phenols, flavonoids, and glycosides 8. It contains anti-inflammatory, antioxidant, and antidiabetic properties 9, 10 and its leaf shows antimicrobial, antidiarrheal, and anticancer properties 11, 12. Molecular modelling is a computational technique employed in drug development and discovery that predicts the best way for small molecules (ligands) to bind to a target receptor or protein's active site 13.

MATERIALS AND METHODS

Ligand selection and preparation:

Several phytochemicals from Bauhinia acuminata were collected from published literature and a library of compounds was used to prepare ligands using Schrodinger's lig prep interface, which was downloaded from the PubChem database 14.

Phytochemical selection and preparation: Several phytochemicals from Bauhinia acuminata were collected from published literature and a library of compounds was used to prepare ligands using Schrodinger's ligprep interface, which was downloaded from the PubChem database [14]. Figure 1: Bauhinia acuminata L. Protein selection and preparation: Refining the protein and generating a grid are important for proper docking. The protein data bank [15] will provide the three-dimensional structure of the target, H+K+ ATPase, using PDB IDs 5YLU [16], 6JXI [18], and 7W47 [17]. All bound water molecules, unneeded atoms, and all bound ligands were removed from the protein during refinement. Structures were prepared by adding hydrogen atoms, removing alternate conformations, and adding missing atoms to incomplete residues. [15]. 

Protein selection and preparation:

Refining the protein and generating a grid are important for proper docking. The protein data bank will provide the spatial structure of the target, H+K+ ATPase 15, using Pdb IDs 5YLU 16, 6JXI 18, and 7W47 17. All bound water molecules, unneeded atoms, and all bound ligands were removed from the protein during refinement. Structures were prepared by adding hydrogen atoms, removing alternate conformations, and adding missing atoms to incomplete residues. 15.

Figure 1:   Bauhinia acuminata L

Molecular docking:

We used the Glide tool on Maestro 12.8 to do docking analysis. The library of ligands, or phytochemicals, was made and placed in the target protein's active site with standard precision (SP) and extra precision (XP) replacing the flexible ligand sampling and only used for refinement.13

To check the docking process, the co-crystallized ligands (HKT, PCW, and 8BN) were re-introduced into the active sites of H+/K+-ATPase (PDB IDs: 5YLU, 6JXI, and 7W47). We compared the docking scores and binding orientations we got with the native ligand conformations to make sure that the docking process was reliable and accurate.19

 

Table 1: Docking score of co-crystallized ligands

SL

NO

COMPOUND NAME

DOCKING SCORE (kcal/mol)

 

Amino acids at protein active site

Pdb id: -

 

5ylu

6jxi

7w47

 

1

Apigenin

-7.09

-2.52

-8.21

LEU811, ASP137, TYR799, VAL341, GLN884, GLH795, ASN138

2

Baicalein

-7.43

-4.04

-9.81

ASP137, ASN138, GLN884, LEU811, GLH795

3

Kaempferol

-7.15

-3.28

-8.83

ASP137, GLH795, GLN884, LEU811

4

Lupeol

No interaction

-1.703

-4.42

Not detected

5

Pentahydroxy

Flavone

-7.92

No interaction

-8.90

GLH795, ASN138, ALA335, ASP132

6

Phlorizin

-8.87

-5.515

-10.90

GLN127, ARG328, TYR799, GLH795, GLN884, THR880, LEU811, ASP137, ASP132, VAL331

7

Pterosin

-5.74

-1.66

-5.69

ASN138, GLN127

8

Quercetin

-8.17

-4.85

-10.60

ASP137, GLH795, GLU343, GLN884, VAL1000, LEU811, VAL331

9

Berberine

-5.17

-0.66

-4.17

ASP137, GLN924, GLU900, ASP132, TYR799

Table 2: Docking scores of the investigated compounds with H?/K?-ATPase (using PDBstructures 5YLU, 6JXI, and 7W47)

PDB ID

Co-crystal Ligand

Docking score

Key interactions

5YLU

HKT

-8.871

GLU343, ALA339

6JXI

PCW

-2.663

GLN996, ARG994, GLU885

7W47

8BN

-7.827

LEU811, ASP137, ASP132, TYR799, VAL331

 

ADMET analysis:

The Qikprop tool was then used to test the hit compounds. The tool was used to predict the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of the compounds including physicochemical parameters such as QPlogPC16, hydrogen bond donors/acceptors, Lipinski’s rule of five, bioavailability score, P-glycoprotein substrate specificity, gastrointestinal absorption, blood–brain barrier permeability, and hepatotoxicity.13

 

 

Table 3:  ADMET prediction of the identified phytoconstituents using SwissADME

S/N

Compound

name

Mol. Weight

(g/mol)

H-bond

acceptors

H-bond

donors

QPlogPC16

Lipinski

violations

1.

Apigenin

270.241

3.75

2

9.706

0

2.

Baicalein

270.241

3.75

2

9.66

0

3.

Kaempferol

286.24

4.5

3

10.242

0

4.

Lupeol

426.724

1.7

1

11.612

1

5.

Pentahydroxy

Flavone

392.318

7.5

4

11.38

0

6.

Phlorizin

436.415

12.5

6

15.00

1

7.

Pterosin

218.295

3.7

1

6.9

0

8.

quercetin

302.24

5.25

4

10.742

0

 

RESULT AND DISCUSSION

To verify the reliability of the docking protocol, the co-crystallized ligands of the target proteins (PDB IDs: 5YLU, 6JXI, and 7W47) were re-docked into their corresponding active binding sites. The docking scores were −8.871 kcal/mol for 5YLU, −2.663 kcal/mol for 6JXI, and −7.827 kcal/mol for 7W47. The re-docked ligand poses fit well with their original crystallographic shapes, which shows that the docking protocol worked. This validation step makes sure that the ligand–protein interactions are structurally reliable and reduces the number of false-positive predictions.

Docking against PDB ID: 5YLU

Phlorizin had the strongest binding affinity of the tested compounds (−8.87 kcal/mol), then Quercetin (−8.17 kcal/mol) and Pentahydroxy flavone (−7.92 kcal/mol). The docking score of Phlorizin (−8.871 kcal/mol) was comparable to that of the co-crystal ligand, which means that it binds strongly to the active site. These values were much better than those of the reference compound Berberine (−5.17 kcal/mol), which suggests that flavonoid derivatives may be better at stopping things.

Docking against PDB ID: 6JXI

The 6JXI conformation was more favourable for binding Phlorizin (−5.515 kcal/mol) and Quercetin (−4.85 kcal/mol) than Berberine (−0.66 kcal/mol). Lower docking scores for this protein structure suggest that the binding pocket could alter its shape, which could affect ligand fit. Even though the docking scores were lower for this protein conformation, the phytoconstituents still had a stronger binding affinity than the co-crystal ligand (−2.663 kcal/mol). This suggests that they may be able to adapt to changes in the binding site's structure.

Docking against PDB ID: 7W47

The most favourable interactions were distinctly noted with PDB ID: 7W47. Phlorizin had the strongest binding affinity (−10.90 kcal/mol), then closely by Quercetin (−10.60 kcal/mol) and Baicalein (−9.81 kcal/mol). These values were much better than the co-crystal ligand (−7.827 kcal/mol), which means that the phytoconstituents in the active site bind more strongly and stably. These findings suggest that this protein conformation may more accurately depict the active inhibitory site of H?/K?-ATPase.

 

 

Table 4: Predicted pharmacokinetic profiles of the selected phytoconstituents

Compound name

Drug likeness

Bioavailability

Score (%)

p-g substrate

specificity

Gi absorption rate

BBB permeability

Apigenin

yes

3

No

High

No

Baicalein

Yes

3

No

High

No

Kaempferol

Yes

3

No

High

Non

Lupeol

No

1

Yes

Low

No

Pentahydroxy

Flavone

Yes

2

Yes

Moderate

No

Phlorizin

No

2

Yes

Moderate

No

Pterosin

Yes

3

No

High

No

Quercetin

yes

2

no

Moderate

No

 

Interaction of the active compounds with protein–ligand analysis revealed that the active compounds mainly bound to key amino acid residues in the H?/K?-ATPase binding pocket, such as ASP137, GLH795, GLN884, LEU811, ASN138, and TYR799. The two stabilizing factors were hydrophobic interactions and hydrogen bonds. The high docking score of phlorizin can be attributed to the several interactions with key residues, and quercetin showed stable binding with GLH795 and ASP137. ADMET profiling revealed that the majority of compounds followed Lipinski's criteria for drug likeness, except Lupeol & Phlorizin, which showed one infraction, while apigenin, baicalein, kaempferol, and pterosin were predicted to have good gastrointestinal absorption, and lupeol was predicted to have poor absorption. Some of the compounds found to be P-glycoprotein substrates may affect bioavailability. None of the phytochemicals were expected to penetrate the blood-brain barrier. Although phlorizin has the highest docking affinity, its therapeutic potential may be limited due to pharmacokinetic limitations. Quercetin, on the other hand, shows good ADMET properties and strong binding affinity, making it the most promising lead compound. Overall, the comparison with co-crystal ligands shows that many phytoconstituents have the same or better binding affinity, which shows that they could be good natural inhibitors of gastric proton pump.

 

Figure2: Ligand Interaction diagram of phytochemicals (a) apigenin, (b) quercetin, (c) baicalein, (d) kaempferol

 

CONCLUSION

The in- silico analysis conducted in this study identified Quercetin, Baicalein, and Apigenin as promising inhibitors of H?/K?-ATPase. These phytoconstituents exhibited strong binding affinities and favourable ADMET profiles, outperforming the reference compound Berberine. The reliability and accuracy of the molecular docking protocol were successfully validated using co-crystallized ligands. Among the tested compounds, Quercetin stood out as the most promising lead candidate due to its well-balanced pharmacokinetic profile and significant binding affinity.

These results indicate that phytoconstituents derived from Bauhinia acuminata possess potential as natural antiulcer agents. Nevertheless, additional in vitro and in vivo studies are essential to prove their therapeutic efficacy and safety.

REFERENCES

  1. Falcão HS, Mariath IR, Diniz MFFM, Batista LM, Barbosa-Filho JM. Plants of the American continent with antiulcer activity. Phytomedicine. 2008;15(1-2):132-146.
  2. Falcão HS, Leite JA, Barbosa-Filho JM, Athayde-Filho PF, Chaves MCO, Moura MD, et al. Gastric and duodenal antiulcer activity of alkaloids: A review. Molecules. 2008;13(2):319-330.
  3. Jain P. Secondary metabolites for antiulcer activity. Int J Pharm Pharm Sci. 2015;7(6):1- 4.
  4. Li H, Meng L, Liu F, Wei JF, Wang YQ. H?/K?-ATPase inhibitors: a patent review. Expert Opin Ther Pat. 2013;23(1):99-111.
  5. Murakami S, Muramatsu M, Aihara H, Otomo S. Inhibition of gastric H?,K?-ATPase by the anti-ulcer agent, sofalcone. Jpn J Pharmacol. 1992;58(1):21–28.
  6. Shanika LGT, Reynolds A, Pattison S, Braund R. Proton pump inhibitor use: systematic review of global trends and practices. Eur J Clin Pharmacology. 2021;77(3):1–10. doi:10.1007/s00228-020-03082-5.
  7. Pandey V, Patel S, Danai P, Yadav G, Kumar A. Phyto-constituents profiling of Prosopis cineraria and in vitro assessment of antioxidant and anti-ulcerogenicity activities. J Ethnopharmacology. 2021;267:113544.
  8. Sravika N, Priya S, Divya N, Sai Jyotsna PM, Anusha P, Kudumula N, et al. Swiss ADME properties screening of the phytochemical compounds present in Bauhinia acuminata. J Pharm Res Int. 2022;34.
  9. Singharoy S, Pal D, Das S, Ghosh D. In vitro anti-diabetic and anti-oxidative evaluation of hydro-methanol bark extract of Bauhinia acuminata (L.). Int J Pharm Sci Res. 2016;7(8):3326–3332.
  10. Dutta S, Hossain S, Islam E, Haque U, Parvin S. Assessment of antioxidant and anti-inflammatory activities of stem bark of Bauhinia acuminata L. J Pharmacogn Phytochem. 2018;7(3):2664–2668.
  11. Sebastian D, Anusha R. Bauhinia acuminata L. attenuates lung cancer cell proliferation: in vitro, in vivo and in silico approaches. J Ethnopharmacol. 2022;283:114691.
  12. Islam MN, Reyad-ul-Ferdous M, Fahad MAB, Hossain MR, Mukti M. In-vivo antidiarrheal and in-vitro antimicrobial activities of the leaf extracts of Bauhinia acuminata. Int J Pharm Sci Res. 2015;6(11):4723–4729.
  13. Agoi MD, Olubode SA. α-Amylase inhibitory potential of antidiabetes ligands in Spondias mombin plant extract: molecular docking and ADMET profiling. J Biomol Struct Dyn. 2023;41(9):3948–3958.
  14. David TI, Adelakun NS, Omotuyi OI, Metibemu DS, Ekun OE, Eniafe GO, et al. Molecular docking analysis of phyto-constituents from Cannabis sativa with pfDHFR. Bioinformation. 2018;14(7):368–373.
  15. Vora J, Patel S, Sinha S, Sharma S, Srivastava A, Chhabria M, et al. Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV. J Biomol Struct Dyn. 2019;37(12):3150–3166.
  16. Noman M, Qazi NG, Rehman NU, Khan AU. Pharmacological investigation of brucine anti-ulcer potential. Front Pharmacol. 2022;13:886433.
  17. Ikpa CBC, Tochukwu OM. In silico molecular studies of the phytochemicals in ethanolic extract of Chromolaena odorata against H?/K?-ATPase enzyme as proton pump inhibitors. J Biomol Struct Dyn. 2022;40(18):8905–8916.
  18. Abe K, Yamamoto K, Irie K, Nishizawa T, Oshima A. Gastric proton pump with two occluded K? engineered with sodium pump–mimetic mutations. Nat Commun. 2018;9:1787.
  19. Friesner RA, Banks JL, Murphy RB, et al.Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.Journal of Medicinal Chemistry. 2004;47(7):1739–1749

Reference

  1. Falcão HS, Mariath IR, Diniz MFFM, Batista LM, Barbosa-Filho JM. Plants of the American continent with antiulcer activity. Phytomedicine. 2008;15(1-2):132-146.
  2. Falcão HS, Leite JA, Barbosa-Filho JM, Athayde-Filho PF, Chaves MCO, Moura MD, et al. Gastric and duodenal antiulcer activity of alkaloids: A review. Molecules. 2008;13(2):319-330.
  3. Jain P. Secondary metabolites for antiulcer activity. Int J Pharm Pharm Sci. 2015;7(6):1- 4.
  4. Li H, Meng L, Liu F, Wei JF, Wang YQ. H?/K?-ATPase inhibitors: a patent review. Expert Opin Ther Pat. 2013;23(1):99-111.
  5. Murakami S, Muramatsu M, Aihara H, Otomo S. Inhibition of gastric H?,K?-ATPase by the anti-ulcer agent, sofalcone. Jpn J Pharmacol. 1992;58(1):21–28.
  6. Shanika LGT, Reynolds A, Pattison S, Braund R. Proton pump inhibitor use: systematic review of global trends and practices. Eur J Clin Pharmacology. 2021;77(3):1–10. doi:10.1007/s00228-020-03082-5.
  7. Pandey V, Patel S, Danai P, Yadav G, Kumar A. Phyto-constituents profiling of Prosopis cineraria and in vitro assessment of antioxidant and anti-ulcerogenicity activities. J Ethnopharmacology. 2021;267:113544.
  8. Sravika N, Priya S, Divya N, Sai Jyotsna PM, Anusha P, Kudumula N, et al. Swiss ADME properties screening of the phytochemical compounds present in Bauhinia acuminata. J Pharm Res Int. 2022;34.
  9. Singharoy S, Pal D, Das S, Ghosh D. In vitro anti-diabetic and anti-oxidative evaluation of hydro-methanol bark extract of Bauhinia acuminata (L.). Int J Pharm Sci Res. 2016;7(8):3326–3332.
  10. Dutta S, Hossain S, Islam E, Haque U, Parvin S. Assessment of antioxidant and anti-inflammatory activities of stem bark of Bauhinia acuminata L. J Pharmacogn Phytochem. 2018;7(3):2664–2668.
  11. Sebastian D, Anusha R. Bauhinia acuminata L. attenuates lung cancer cell proliferation: in vitro, in vivo and in silico approaches. J Ethnopharmacol. 2022;283:114691.
  12. Islam MN, Reyad-ul-Ferdous M, Fahad MAB, Hossain MR, Mukti M. In-vivo antidiarrheal and in-vitro antimicrobial activities of the leaf extracts of Bauhinia acuminata. Int J Pharm Sci Res. 2015;6(11):4723–4729.
  13. Agoi MD, Olubode SA. α-Amylase inhibitory potential of antidiabetes ligands in Spondias mombin plant extract: molecular docking and ADMET profiling. J Biomol Struct Dyn. 2023;41(9):3948–3958.
  14. David TI, Adelakun NS, Omotuyi OI, Metibemu DS, Ekun OE, Eniafe GO, et al. Molecular docking analysis of phyto-constituents from Cannabis sativa with pfDHFR. Bioinformation. 2018;14(7):368–373.
  15. Vora J, Patel S, Sinha S, Sharma S, Srivastava A, Chhabria M, et al. Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV. J Biomol Struct Dyn. 2019;37(12):3150–3166.
  16. Noman M, Qazi NG, Rehman NU, Khan AU. Pharmacological investigation of brucine anti-ulcer potential. Front Pharmacol. 2022;13:886433.
  17. Ikpa CBC, Tochukwu OM. In silico molecular studies of the phytochemicals in ethanolic extract of Chromolaena odorata against H?/K?-ATPase enzyme as proton pump inhibitors. J Biomol Struct Dyn. 2022;40(18):8905–8916.
  18. Abe K, Yamamoto K, Irie K, Nishizawa T, Oshima A. Gastric proton pump with two occluded K? engineered with sodium pump–mimetic mutations. Nat Commun. 2018;9:1787.
  19. Friesner RA, Banks JL, Murphy RB, et al.Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.Journal of Medicinal Chemistry. 2004;47(7):1739–1749

 

Photo
Alagha k
Corresponding author

Student, Department of Pharmaceutical Chemistry Al Shifa college of pharmacy, Kizhattur, Perinthalmanna.

Photo
Neethu Varghese
Co-author

Associate professor Department of Pharmaceutical Chemistry Al Shifa college of pharmacy, Kizhattur, Perinthalmanna.

Photo
Amrutha Anil
Co-author

Department of Pharmaceutical Chemistry Al Shifa college of pharmacy, Kizhattur, Perinthalmanna.

Photo
Artha Rajagopal K
Co-author

Department of Pharmaceutical Chemistry Al Shifa college of pharmacy, Kizhattur, Perinthalmanna.

Photo
Fathima C O
Co-author

Department of Pharmaceutical Chemistry Al Shifa college of pharmacy, Kizhattur, Perinthalmanna.

Photo
Hiba Abdul Razak
Co-author

Department of Pharmaceutical Chemistry Al Shifa college of pharmacy, Kizhattur, Perinthalmanna.

Photo
Megha Santhosh M
Co-author

Department of Pharmaceutical Chemistry Al Shifa college of pharmacy, Kizhattur, Perinthalmanna.

Alagha K, Neethu Varghese, Amrutha Anil, Artha Rajagopal K, Fathima C O, Hiba Abdul Razak, Megha Santhosh M, Molecular Docking and ADMET Analysis of Bauhinia Acuminata Phytoconstituents Against Gastric H+/K+ Atpase, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 9, 3088-3095, https://doi.org/10.5281/zenodo.22939288

More related articles
Comperhensive Review of Piles: Treatment Statery H...
Nitin Kale, Dr Gajanan Sanap, Dhiraj Gawai, Shivajiraj Satpute, G...
Formulation And Evaluation of Terminalia Chebula R...
Manojkumar M, Senthil Kumar K L , Vasanthan A...
Doxycycline: More Than An Antibiotic...
Mano Gayathri S., Arunmozhi U. , Iswarya T., Jenifer Cynthia R. A...
Evaluating the Efficacy of an Artificial Intelligence-Driven Mobile Application ...
Dr. Vinothini M., N. Rakshith, R. Ragupathi, N. Ragavi, A. Pugazhenthi, R. Priyadharsini, Dr. S. Moh...
Development and Validation of an HPTLC Method for the Quantitative Analysis of F...
Poovizhi K, Maha Gowri K S, Madheswaran B, Logeshwaran P, Kumaresan R, Krishnamathesh S, Gowsalya M...
Related Articles
A Validated RP-HPLC Method for Simultaneous Estimation of Empagliflozin and Lin...
Dr. M. Suchitra, Dr. Y.Praurnachandra, Dr. P.Venugopalaih, Shobha V, Sivakumar Dayana...
Qvality Of Life Unvelied: The Role of Antiviral Treatment Hepatitis C Recovery...
C. Umesh Chandra , Kasula Satwika, B. Triveni, Dr. S. Kusuma Kumari ...
Polyherbal Formulations and Sustained Release Drug Delivery Systems: A Comprehen...
Sahil Sharma, Amar Pal Singh, Ajeet Pal Singh, Rajesh Kumar...
Comperhensive Review of Piles: Treatment Statery Herbal Remedies & Synthetic Dru...
Nitin Kale, Dr Gajanan Sanap, Dhiraj Gawai, Shivajiraj Satpute, Ganesh Raut...
More related articles
Comperhensive Review of Piles: Treatment Statery Herbal Remedies & Synthetic Dru...
Nitin Kale, Dr Gajanan Sanap, Dhiraj Gawai, Shivajiraj Satpute, Ganesh Raut...
Doxycycline: More Than An Antibiotic...
Mano Gayathri S., Arunmozhi U. , Iswarya T., Jenifer Cynthia R. A....
Comperhensive Review of Piles: Treatment Statery Herbal Remedies & Synthetic Dru...
Nitin Kale, Dr Gajanan Sanap, Dhiraj Gawai, Shivajiraj Satpute, Ganesh Raut...
Doxycycline: More Than An Antibiotic...
Mano Gayathri S., Arunmozhi U. , Iswarya T., Jenifer Cynthia R. A....